3 Followers on Owler
ARS is a clinical-stage pharmaceutical firm that develops intranasal epinephrine spray for the treatment of allergic reactions... Read more
OverviewCompetitorsFundingNews & Insights
ARS is a clinical-stage pharmaceutical firm that develops intranasal epinephrine spray for the treatment of allergic reactions... Read more
ARS Pharmaceuticals President & CEO: Richard Lowenthal

President & CEO

Richard Lowenthal

CEO Approval Rating

70/100

2015

PublicMerged with Silverback Therapeutics, Inc.NASDAQSPRY

Pharmaceuticals & Biotechnology
Pharmaceuticals
2834 NAICS listing

Annual Revenue
$89.1M
Employees
90
Funding
$83.2M

News

Conference Presentation
Feb 05, 2025
GlobeNewswire
ARS Pharmaceuticals to Participate in the Oppenheimer 35th Annual Healthcare Conference

ARS Pharmaceuticals Competitors

1Similasan Corporation
2KC Pharmaceuticals
3Trusted Tablets
4Orasis
5Neemking
6Cesca
7Eye Care and Cure
8Pacific Institute Of Aromatherapy
9CytomX
10XIIDRA
Unlock 17 + competitors

Trending Companies